Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE 14.03% 13.95% 14.10% 13.64%

+8 more TTM periods
ROA 6.43% 6.28% 6.10% 5.97%
ROIC 7.94% 7.78% 7.81% 7.63%
Return on Tangible Assets 32.31% 39.57% 42.90% 39.87%
Average Days of Receivables 52.60 51.36 46.57 48.98
Free Cash Flow per Share 12.15 12.05 12.24 12.44
Free Cash Flow 1,349.00 1,326.00 1,359.00 1,393.00
Capital Expenditures (554.00) (524.00) (527.00) (492.00)
Piotroski F-Score 7.00 7.00 7.00 7.00
Other line items
Cash ROIC 13.51% 13.49% 14.18% 14.07%
Accounts Receivable Turnover 7.49 7.54 8.14 7.66
Accounts Payable Turnover 5.25 5.45 4.92 5.23
Inventory Turnover 36.82 36.40 39.10 39.12
Average Days of Payables 75.44 72.67 79.24 73.48
Days of Inventory on Hand 11.00 10.90 9.36 9.38
Tax Rate (0.23) (0.24) (0.24) (0.23)
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 17.63% 17.69% 17.83% 17.78%
Share Based Compensation of Revenue 0.76% 0.76% 0.80% 0.83%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income 1.80 1.81 1.91 1.96
Depreciation/Fixed assets 0.26 0.26 0.26 0.26
Capex/Depreciation (0.96) (0.91) (0.92) (0.88)
Revenue per Share 104.14 102.53 99.41 96.88
Operating CF per Share 17.14 16.82 16.99 16.83
Capex per Share (4.99) (4.76) (4.75) (4.39)
Capex to Sales 0.05 0.05 0.05 0.05
Net Profit Margin 9.15% 9.04% 8.95% 8.88%

Fold the line items

Columns are period end dates